Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
420458/2023-9
Funder:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Funded outputs count:
6
Funder award ID:
420458/2023-9
OpenAlex ID:
G6901580720
Testosterone replacement therapy in Parkinson’s disease a narrative review of current evidence
2026
·
José Leandro S. Souza
, Gabriel S. Rocha
, et al.
·
Discover Neuroscience
PDF
Repeated clethodim exposure induces behavioral alterations and reduces hippocampal BDNF in rats
2026
·
Abraão J. Barbosa
, Cássia E.J. Lima
, et al.
·
NeuroToxicology
PDF
Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease
2026
·
Clarissa G.A. Alvaia
, Pollyana C. Leal
, et al.
·
Pharmacology Biochemistry and Behavior
Neuroinflammation and noradrenergic modulation with β2-adrenoceptors: Emerging therapeutic targets for Parkinson’s diseases
2026
·
Maria Micaelle Gomes Tavares
, Milena Caroline Nunes Monteiro de Carvalho
, et al.
·
Neural Regeneration Research
Motor impairments and increased GFAP expression in different stages of a progressive model of parkinsonism induced by reserpine
2025
·
Edson R. Santos
, Thassya F.O. Santos
, et al.
·
Physiology & Behavior
·
1
Patterns of BDNF expression in the dorsal striatum and cognitive processing areas during aging in a progressive model of parkinsonism
2025
·
Mylaine S. Mendonça
, João E.C. Melo
, et al.
·
Brain Mechanisms
·
3
Show more works
View as search